Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Characteristics of HIV-infected U.S. Army soldiers linked in molecular transmission clusters, 2001-2012.

Hakre S, Jagodzinski LL, Liu Y, Pham PT, Kijak GH, Tovanabutra S, McCutchan FE, Scoville SL, Cersovsky SB, Michael NL, Scott PT, Peel SA.

PLoS One. 2017 Jul 31;12(7):e0182376. doi: 10.1371/journal.pone.0182376. eCollection 2017.

2.

The Number and Complexity of Pure and Recombinant HIV-1 Strains Observed within Incident Infections during the HIV and Malaria Cohort Study Conducted in Kericho, Kenya, from 2003 to 2006.

Billings E, Sanders-Buell E, Bose M, Bradfield A, Lei E, Kijak GH, Arroyo MA, Kibaya RM, Scott PT, Wasunna MK, Sawe FK, Shaffer DN, Birx DL, McCutchan FE, Michael NL, Robb ML, Kim JH, Tovanabutra S.

PLoS One. 2015 Aug 19;10(8):e0135124. doi: 10.1371/journal.pone.0135124. eCollection 2015.

3.

An effective tool for identifying HIV-1 subtypes B, C, CRF01_AE, their recombinant forms, and dual infections in Southeast Asia by the multi-region subtype specific PCR (MSSP) assay.

Sakkhachornphop S, Kijak GH, Beyrer C, Razak MH, Sanders-Buell E, Jittiwutikarn J, Suriyanon V, Robb ML, Kim JH, Celentano DD, McCutchan FE, Tovanabutra S.

J Virol Methods. 2015 Jun 1;217:70-8. doi: 10.1016/j.jviromet.2015.02.015. Epub 2015 Feb 25.

PMID:
25725414
4.

Impact of HIV-1 backbone on neutralization sensitivity: neutralization profiles of heterologous envelope glycoproteins expressed in native subtype C and CRF01_AE backbone.

Chenine AL, Wieczorek L, Sanders-Buell E, Wesberry M, Towle T, Pillis DM, Molnar S, McLinden R, Edmonds T, Hirsch I, O'Connell R, McCutchan FE, Montefiori DC, Ochsenbauer C, Kappes JC, Kim JH, Polonis VR, Tovanabutra S.

PLoS One. 2013 Nov 29;8(11):e76104. doi: 10.1371/journal.pone.0076104. eCollection 2013.

5.

Natural killer cell-mediated innate sieve effect on HIV-1: the impact of KIR/HLA polymorphism on HIV-1 subtype-specific acquisition in east Africa.

Koehler RN, Alter G, Tovanabutra S, Saathoff E, Arroyo MA, Walsh AM, Sanders-Buell EE, Maboko L, Hoelscher M, Robb ML, Michael NL, McCutchan FE, Kim JH, Kijak GH.

J Infect Dis. 2013 Oct 15;208(8):1250-4. doi: 10.1093/infdis/jit349. Epub 2013 Aug 6.

6.

Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trial.

Kijak GH, Tovanabutra S, Rerks-Ngarm S, Nitayaphan S, Eamsila C, Kunasol P, Khamboonruang C, Thongcharoen P, Namwat C, Premsri N, Benenson M, Morgan P, Bose M, Sanders-Buell E, Paris R, Robb ML, Birx DL, De Souza MS, McCutchan FE, Michael NL, Kim JH.

J Virol. 2013 Jul;87(13):7265-81. doi: 10.1128/JVI.03070-12. Epub 2013 Apr 10. Erratum in: J Virol. 2013 Dec;87(23):13084.

7.

Use of dried blood spots for HIV-1 genotyping in Southeast Asia: Thailand experience.

Rutvisuttinunt W, Arroyo MA, Assawadarachai V, Poltavee K, McCutchan FE, Tovanabutra S, Kijak G, Kim JH, Paris RM, de Souza M.

Southeast Asian J Trop Med Public Health. 2012 Mar;43(2):333-9.

PMID:
23082585
8.

Short communication: Investigation of incident HIV infections among U.S. army soldiers deployed to Afghanistan and Iraq, 2001-2007.

Scott PT, Hakre S, Myles O, Sanders-Buell EE, Kijak GH, McCutchan FE, O'Connell RJ, Peel SA, Eggleston JC, Sateren WB, Robb-McGrath M, Mott RL, Tobler SK, Nolan E, Petruccelli BP, Michael NL, Cersovsky SB.

AIDS Res Hum Retroviruses. 2012 Oct;28(10):1308-12. Epub 2012 Mar 13.

9.

Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial.

Campbell MS, Mullins JI, Hughes JP, Celum C, Wong KG, Raugi DN, Sorensen S, Stoddard JN, Zhao H, Deng W, Kahle E, Panteleeff D, Baeten JM, McCutchan FE, Albert J, Leitner T, Wald A, Corey L, Lingappa JR; Partners in Prevention HSV/HIV Transmission Study Team.

PLoS One. 2011 Mar 2;6(3):e16986. doi: 10.1371/journal.pone.0016986.

10.

Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial.

Rolland M, Tovanabutra S, deCamp AC, Frahm N, Gilbert PB, Sanders-Buell E, Heath L, Magaret CA, Bose M, Bradfield A, O'Sullivan A, Crossler J, Jones T, Nau M, Wong K, Zhao H, Raugi DN, Sorensen S, Stoddard JN, Maust BS, Deng W, Hural J, Dubey S, Michael NL, Shiver J, Corey L, Li F, Self SG, Kim J, Buchbinder S, Casimiro DR, Robertson MN, Duerr A, McElrath MJ, McCutchan FE, Mullins JI.

Nat Med. 2011 Mar;17(3):366-71. doi: 10.1038/nm.2316. Epub 2011 Feb 27.

11.

Socio-demographic and drug use factors associated with HIV-1 recombinants and dual infections in Northern Thai drug users: associations of risk with genetic complexity.

Kijak GH, Beyrer C, Tovanabutra S, Sripaipan T, Suriyanon V, Moqueet N, Sanders-Buell E, Saokhieo P, Timpan U, Jittiwutikarn J, Robb ML, Birx DL, Celentano DD, McCutchan FE.

Drug Alcohol Depend. 2011 Jul 1;116(1-3):24-30. doi: 10.1016/j.drugalcdep.2010.11.013. Epub 2010 Dec 28.

PMID:
21193272
12.

RecDraw: a software package for the representation of HIV-1 recombinant structures.

Kijak GH, Tovanabutra S, Beyrer C, Sanders-Buell EE, Arroyo MA, Robb ML, Michael NL, McCutchan FE, Kim JH.

AIDS Res Hum Retroviruses. 2010 Dec;26(12):1317-21. doi: 10.1089/aid.2010.0127. Epub 2010 Oct 21.

13.

Transfusion-transmissible viral infections among US military recipients of whole blood and platelets during Operation Enduring Freedom and Operation Iraqi Freedom.

Hakre S, Peel SA, O'Connell RJ, Sanders-Buell EE, Jagodzinski LL, Eggleston JC, Myles O, Waterman PE, McBride RH, Eader SA, Davis KW, Rentas FJ, Sateren WB, Naito NA, Tobler SK, Tovanabutra S, Petruccelli BP, McCutchan FE, Michael NL, Cersovsky SB, Scott PT.

Transfusion. 2011 Mar;51(3):473-85. doi: 10.1111/j.1537-2995.2010.02906.x. Epub 2010 Oct 7.

PMID:
20946199
14.

Class I HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, Tanzania.

Koehler RN, Walsh AM, Saathoff E, Tovanabutra S, Arroyo MA, Currier JR, Maboko L, Hoelscher M, Robb ML, Michael NL, McCutchan FE, Kim JH, Kijak GH.

J Infect Dis. 2010 Nov 15;202(10):1562-6. doi: 10.1086/656913. Epub 2010 Oct 5. Erratum in: J Infect Dis. 2011 Mar;203(5):749. Hoelsher, Michael [corrected to Hoelscher, Michael].

PMID:
20923372
15.

Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1.

Rosa Borges A, Wieczorek L, Johnson B, Benesi AJ, Brown BK, Kensinger RD, Krebs FC, Wigdahl B, Blumenthal R, Puri A, McCutchan FE, Birx DL, Polonis VR, Schengrund CL.

Virology. 2010 Dec 5;408(1):80-8. doi: 10.1016/j.virol.2010.09.004. Epub 2010 Sep 28.

16.

HIV infection among U.S. Army and Air Force military personnel: sociodemographic and genotyping analysis.

Singer DE, Bautista CT, O'Connell RJ, Sanders-Buell E, Agan BK, Kijak GH, Hakre S, Sanchez JL, Sateren WB, McCutchan FE, Michael NL, Scott PT.

AIDS Res Hum Retroviruses. 2010 Aug;26(8):889-94. doi: 10.1089/aid.2009.0289.

PMID:
20673143
17.

Viral and host factors associated with the HIV-1 viral load setpoint in adults from Mbeya Region, Tanzania.

Saathoff E, Pritsch M, Geldmacher C, Hoffmann O, Koehler RN, Maboko L, Maganga L, Geis S, McCutchan FE, Kijak GH, Kim JH, Arroyo MA, Gerhardt M, Tovanabutra S, Robb ML, Williamson C, Michael NL, Hoelscher M.

J Acquir Immune Defic Syndr. 2010 Jul;54(3):324-30.

18.

High-throughput high-resolution class I HLA genotyping in East Africa.

Koehler RN, Walsh AM, Sanders-Buell EE, Eller LA, Eller M, Currier JR, Bautista CT, Wabwire-Mangen F, Hoelscher M, Maboko L, Kim J, Michael NL, Robb ML, McCutchan FE, Kijak GH.

PLoS One. 2010 May 20;5(5):e10751. doi: 10.1371/journal.pone.0010751.

19.

Distinct circulating recombinant HIV-1 strains among injecting drug users and sex workers in Afghanistan.

Sanders-Buell E, Bose M, Nasir A, Todd CS, Stanekzai MR, Tovanabutra S, Scott PT, Strathdee SA, Tjaden J, Michael NL, McCutchan FE.

AIDS Res Hum Retroviruses. 2010 May;26(5):605-8. doi: 10.1089/aid.2009.0226.

20.

HIV-1 recombinants with multiple parental strains in low-prevalence, remote regions of Cameroon: evolutionary relics?

Carr JK, Wolfe ND, Torimiro JN, Tamoufe U, Mpoudi-Ngole E, Eyzaguirre L, Birx DL, McCutchan FE, Burke DS.

Retrovirology. 2010 Apr 28;7:39. doi: 10.1186/1742-4690-7-39.

21.

HIV type 1 molecular epidemiology among high-risk clients attending the Thai Red Cross Anonymous Clinic in Bangkok, Thailand.

Arroyo MA, Phanuphak N, Krasaesub S, Sirivichayakul S, Assawadarachai V, Poltavee K, Pankam T, Ananworanich J, Paris R, Tovanabutra S, Kijak GH, McCutchan FE, Phanuphak P, Kim JH, de Souza M.

AIDS Res Hum Retroviruses. 2010 Jan;26(1):5-12. doi: 10.1089/aid.2009.0150.

PMID:
20055593
22.

Short communication: HIV type 1 genetic diversity among tea plantation workers in Kericho, Kenya.

Arroyo MA, Sateren WB, Foglia G, Kibaya R, Langat L, Wasunna M, Bautista CT, Scott PT, Shaffer DN, Robb ML, Michael NL, Birx DL, McCutchan FE.

AIDS Res Hum Retroviruses. 2009 Nov;25(11):1061-4. doi: 10.1089/aid.2009.0092.

PMID:
19943788
23.

Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies.

Seaman MS, Janes H, Hawkins N, Grandpre LE, Devoy C, Giri A, Coffey RT, Harris L, Wood B, Daniels MG, Bhattacharya T, Lapedes A, Polonis VR, McCutchan FE, Gilbert PB, Self SG, Korber BT, Montefiori DC, Mascola JR.

J Virol. 2010 Feb;84(3):1439-52. doi: 10.1128/JVI.02108-09. Epub 2009 Nov 25.

24.

High-throughput genotyping of KIR2DL2/L3, KIR3DL1/S1, and their HLA class I ligands using real-time PCR.

Koehler RN, Walsh AM, Moqueet N, Currier JR, Eller MA, Eller LA, Wabwire-Mangen F, Michael NL, Robb ML, McCutchan FE, Kijak GH.

Tissue Antigens. 2009 Jul;74(1):73-80. doi: 10.1111/j.1399-0039.2009.01265.x.

PMID:
19522772
25.

Elevated natural killer cell activity despite altered functional and phenotypic profile in Ugandans with HIV-1 clade A or clade D infection.

Eller MA, Eller LA, Ouma BJ, Thelian D, Gonzalez VD, Guwatudde D, McCutchan FE, Marovich MA, Michael NL, de Souza MS, Wabwire-Mangen F, Robb ML, Currier JR, Sandberg JK.

J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):380-9. doi: 10.1097/QAI.0b013e3181aa256e.

PMID:
19487954
26.

HLA class I allele and haplotype diversity in Ugandans supports the presence of a major east African genetic cluster.

Kijak GH, Walsh AM, Koehler RN, Moqueet N, Eller LA, Eller M, Currier JR, Wang Z, Wabwire-Mangen F, Kibuuka HN, Michael NL, Robb ML, McCutchan FE.

Tissue Antigens. 2009 Mar;73(3):262-9. doi: 10.1111/j.1399-0039.2008.01192.x.

PMID:
19254258
27.

Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India.

Kulkarni SS, Lapedes A, Tang H, Gnanakaran S, Daniels MG, Zhang M, Bhattacharya T, Li M, Polonis VR, McCutchan FE, Morris L, Ellenberger D, Butera ST, Bollinger RC, Korber BT, Paranjape RS, Montefiori DC.

Virology. 2009 Mar 15;385(2):505-20. doi: 10.1016/j.virol.2008.12.032. Epub 2009 Jan 23.

28.

Variable contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cells.

Kijak GH, Janini LM, Tovanabutra S, Sanders-Buell E, Arroyo MA, Robb ML, Michael NL, Birx DL, McCutchan FE.

Virology. 2008 Jun 20;376(1):101-11. doi: 10.1016/j.virol.2008.03.017. Epub 2008 Apr 24.

29.

Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models.

Brown BK, Wieczorek L, Sanders-Buell E, Rosa Borges A, Robb ML, Birx DL, Michael NL, McCutchan FE, Polonis VR.

Virology. 2008 Jun 5;375(2):529-38. doi: 10.1016/j.virol.2008.02.022. Epub 2008 Apr 22.

30.

The challenge of HIV-1 subtype diversity.

Taylor BS, Sobieszczyk ME, McCutchan FE, Hammer SM.

N Engl J Med. 2008 Apr 10;358(15):1590-602. doi: 10.1056/NEJMra0706737. Review. No abstract available. Erratum in: N Engl J Med. 2008 Oct 30;359(18):1972. N Engl J Med. 2008 Oct 30;359(18):1965-6.

31.

Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination.

Polonis VR, Brown BK, Rosa Borges A, Zolla-Pazner S, Dimitrov DS, Zhang MY, Barnett SW, Ruprecht RM, Scarlatti G, Fenyƶ EM, Montefiori DC, McCutchan FE, Michael NL.

Virology. 2008 Jun 5;375(2):315-20. doi: 10.1016/j.virol.2008.02.007. Epub 2008 Mar 25. Review.

32.

Antibodies induced by liposomal protein exhibit dual binding to protein and lipid epitopes.

Karasavvas N, Beck Z, Tong J, Matyas GR, Rao M, McCutchan FE, Michael NL, Alving CR.

Biochem Biophys Res Commun. 2008 Feb 22;366(4):982-7. Epub 2007 Dec 26.

PMID:
18088597
33.

A nascent HIV type 1 epidemic among injecting drug users in Kabul, Afghanistan is dominated by complex AD recombinant strain, CRF35_AD.

Sanders-Buell E, Saad MD, Abed AM, Bose M, Todd CS, Strathdee SA, Botros BA, Safi N, Earhart KC, Scott PT, Michael N, McCutchan FE.

AIDS Res Hum Retroviruses. 2007 Jun;23(6):834-9. Erratum in: AIDS Res Hum Retroviruses. 2007 Jul;23(7):953-4.

PMID:
17604548
34.

Identification of CRF34_01B, a second circulating recombinant form unrelated to and more complex than CRF15_01B, among injecting drug users in northern Thailand.

Tovanabutra S, Kijak GH, Beyrer C, Gammon-Richardson C, Sakkhachornphop S, Vongchak T, Jittiwutikarn J, Razak MH, Sanders-Buell E, Robb ML, Suriyanon V, Birx DL, Michael NL, Celentano DD, McCutchan FE.

AIDS Res Hum Retroviruses. 2007 Jun;23(6):829-33.

PMID:
17604547
35.

HIV-1 genetic diversity and compartmentalization in mother/infant pairs infected with CRF01_AE.

Tovanabutra S, de Souza M, Sittisombut N, Sriplienchan S, Ketsararat V, Birx DL, Khamboonrueng C, Nelson KE, McCutchan FE, Robb ML.

AIDS. 2007 May 11;21(8):1050-3.

PMID:
17457103
36.

HyperPack: a software package for the study of levels, contexts, and patterns of APOBEC-mediated hypermutation in HIV.

Kijak GH, Janini M, Tovanabutra S, Sanders-Buell EE, Birx DL, Robb ML, Michael NL, McCutchan FE.

AIDS Res Hum Retroviruses. 2007 Apr;23(4):554-7.

PMID:
17451344
37.

Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2.

Kijak GH, Tovanabutra S, Sanders-Buell E, Watanaveeradej V, de Souza MS, Nelson KE, Ketsararat V, Gulgolgarn V, Wera-arpachai M, Sriplienchan S, Khamboonrueng C, Birx DL, Robb ML, McCutchan FE.

Virology. 2007 Feb 5;358(1):178-91. Epub 2006 Sep 25.

38.

Higher HIV-1 incidence and genetic complexity along main roads in Rakai District, Uganda.

Arroyo MA, Sateren WB, Serwadda D, Gray RH, Wawer MJ, Sewankambo NK, Kiwanuka N, Kigozi G, Wabwire-Mangen F, Eller M, Eller LA, Birx DL, Robb ML, McCutchan FE.

J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):440-5.

PMID:
16980909
39.

Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping.

Watanaveeradej V, Benenson MW, Souza MD, Sirisopana N, Nitayaphan S, Tontichaivanich C, Amphaipit R, Renzullo PO, Brown AE, McNeil JG, Robb ML, Birx DL, Tovanabutra S, Carr JK, McCutchan FE.

AIDS Res Hum Retroviruses. 2006 Aug;22(8):801-7.

PMID:
16910837
40.

Circulating and unique recombinant forms of HIV type 1 containing subsubtype A2.

Visawapoka U, Tovanabutra S, Currier JR, Cox JH, Mason CJ, Wasunna M, Ponglikitmongkol M, Dowling WE, Robb ML, Birx DL, McCutchan FE.

AIDS Res Hum Retroviruses. 2006 Jul;22(7):695-702.

PMID:
16831094
41.

Frequency of HIV type 1 dual infection and HIV diversity: analysis of low- and high-risk populations in Mbeya Region, Tanzania.

Herbinger KH, Gerhardt M, Piyasirisilp S, Mloka D, Arroyo MA, Hoffmann O, Maboko L, Birx DL, Mmbando D, McCutchan FE, Hoelscher M.

AIDS Res Hum Retroviruses. 2006 Jul;22(7):599-606.

PMID:
16831083
42.

Global epidemiology of HIV.

McCutchan FE.

J Med Virol. 2006;78 Suppl 1:S7-S12.

PMID:
16622870
44.

HLA class I diversity among rural rainforest inhabitants in Cameroon: identification of A*2612-B*4407 haplotype.

Torimiro JN, Carr JK, Wolfe ND, Karacki P, Martin MP, Gao X, Tamoufe U, Thomas A, Ngole EM, Birx DL, McCutchan FE, Burke DS, Carrington M.

Tissue Antigens. 2006 Jan;67(1):30-7.

PMID:
16451198
45.

HIV diversity, molecular epidemiology, and the role of recombination.

Kijak GH, McCutchan FE.

Curr Infect Dis Rep. 2005 Nov;7(6):480-8.

PMID:
16225787
46.

In-depth analysis of a heterosexually acquired human immunodeficiency virus type 1 superinfection: evolution, temporal fluctuation, and intercompartment dynamics from the seronegative window period through 30 months postinfection.

McCutchan FE, Hoelscher M, Tovanabutra S, Piyasirisilp S, Sanders-Buell E, Ramos G, Jagodzinski L, Polonis V, Maboko L, Mmbando D, Hoffmann O, Riedner G, von Sonnenburg F, Robb M, Birx DL.

J Virol. 2005 Sep;79(18):11693-704.

47.

HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania.

Arroyo MA, Hoelscher M, Sateren W, Samky E, Maboko L, Hoffmann O, Kijak G, Robb M, Birx DL, McCutchan FE.

AIDS. 2005 Sep 23;19(14):1517-24.

PMID:
16135906
48.

HIV-1 envelope pseudotyped viral vectors and infectious molecular clones expressing the same envelope glycoprotein have a similar neutralization phenotype, but culture in peripheral blood mononuclear cells is associated with decreased neutralization sensitivity.

Louder MK, Sambor A, Chertova E, Hunte T, Barrett S, Ojong F, Sanders-Buell E, Zolla-Pazner S, McCutchan FE, Roser JD, Gabuzda D, Lifson JD, Mascola JR.

Virology. 2005 Sep 1;339(2):226-38.

49.

In-depth, longitudinal analysis of viral quasispecies from an individual triply infected with late-stage human immunodeficiency virus type 1, using a multiple PCR primer approach.

Gerhardt M, Mloka D, Tovanabutra S, Sanders-Buell E, Hoffmann O, Maboko L, Mmbando D, Birx DL, McCutchan FE, Hoelscher M.

J Virol. 2005 Jul;79(13):8249-61.

50.

Characterization of complete HIV type 1 genomes from non-B subtype infections in U.S. military personnel.

Tovanabutra S, Brodine SK, Mascola JR, Sankale JL, Sanders-Buell E, Kim B, Birx DL, McCutchan FE.

AIDS Res Hum Retroviruses. 2005 May;21(5):424-9.

PMID:
15929707

Supplemental Content

Loading ...
Support Center